PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.
Clinical trial NCT03901131 · COMPLETED
Trial details
- NCT number
- NCT03901131
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-26
- Primary completion
- 2021-08-31
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.